Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 9Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Glioblastoma 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Glioma 3Fallopian Tube Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Skin Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Brain Neoplasms 2Uveal Melanoma 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

Cyclophosphamide 20Trastuzumab 12Epirubicin 12Doxorubicin 12Docetaxel 11Paclitaxel 10Filgrastim 8Carboplatin 7Radiotherapy 6Bevacizumab 5Neoadjuvant Therapy 4Lapatinib 4Granulocyte Colony-Stimulating Factor 4Albumin-Bound Paclitaxel 4tipifarnib 3pertuzumab 3pegfilgrastim 3Thiotepa 3Taxes 3Tamoxifen 3Surgical Procedures, Operative 3Melphalan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3130-nm albumin-bound paclitaxel 3Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammatory Breast Neoplasms × poly ICLC × Clear all
NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡